Vaccination

BioNTech eyes COVID vaccine for 12-15 year olds from June in EU

Credit: Pixabay/CC0 Public Domain

BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.

The German firm’s CEO Ugur Sahin told Der Spiegel weekly that it was “in the final stretches” of preparing its submission for European regulatory approval. The evaluation of the trial data “takes four to six weeks on average”, he added.


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2021 AFP

Citation:
BioNTech eyes COVID vaccine for 12-15 year olds from June in EU (2021, April 29)
retrieved 29 April 2021
from https://medicalxpress.com/news/2021-04-biontech-eyes-covid-vaccine-.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.